vs
Side-by-side financial comparison of AMERICAN PUBLIC EDUCATION INC (APEI) and Esperion Therapeutics, Inc. (ESPR). Click either name above to swap in a different company.
Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $158.3M, roughly 1.1× AMERICAN PUBLIC EDUCATION INC). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs -3.5%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs 1.3%).
Strategic Education, Inc. (SEI) is an education services holding company and is formerly known as Strayer Education, Inc. The company owns for-profit, online Capella University and Strayer University, as well as non-degree programs schools such as DevMountain, Hackbright Academy, and Sophia Learning.
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
APEI vs ESPR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $158.3M | $168.4M |
| Net Profit | $12.6M | — |
| Gross Margin | 56.4% | — |
| Operating Margin | 12.0% | 50.6% |
| Net Margin | 8.0% | — |
| Revenue YoY | -3.5% | 143.7% |
| Net Profit YoY | -2.7% | — |
| EPS (diluted) | $0.67 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $158.3M | $168.4M | ||
| Q3 25 | $163.2M | $87.3M | ||
| Q2 25 | $162.8M | $82.4M | ||
| Q1 25 | $164.6M | $65.0M | ||
| Q4 24 | $164.1M | $69.1M | ||
| Q3 24 | $153.1M | $51.6M | ||
| Q2 24 | $152.9M | $73.8M | ||
| Q1 24 | $154.4M | $137.7M |
| Q4 25 | $12.6M | — | ||
| Q3 25 | $5.6M | $-31.3M | ||
| Q2 25 | $4.5M | $-12.7M | ||
| Q1 25 | $8.9M | $-40.5M | ||
| Q4 24 | $13.0M | — | ||
| Q3 24 | $2.3M | $-29.5M | ||
| Q2 24 | $371.0K | $-61.9M | ||
| Q1 24 | $516.0K | $61.0M |
| Q4 25 | 56.4% | — | ||
| Q3 25 | 54.2% | — | ||
| Q2 25 | 51.8% | — | ||
| Q1 25 | 54.5% | — | ||
| Q4 24 | 56.3% | — | ||
| Q3 24 | 50.8% | — | ||
| Q2 24 | 50.2% | — | ||
| Q1 24 | 53.1% | — |
| Q4 25 | 12.0% | 50.6% | ||
| Q3 25 | 5.9% | -11.4% | ||
| Q2 25 | 4.3% | 8.6% | ||
| Q1 25 | 7.4% | -34.0% | ||
| Q4 24 | 13.1% | -6.4% | ||
| Q3 24 | 2.7% | -31.0% | ||
| Q2 24 | 1.5% | 3.5% | ||
| Q1 24 | 3.4% | 52.5% |
| Q4 25 | 8.0% | — | ||
| Q3 25 | 3.4% | -35.9% | ||
| Q2 25 | 2.8% | -15.4% | ||
| Q1 25 | 5.4% | -62.2% | ||
| Q4 24 | 7.9% | — | ||
| Q3 24 | 1.5% | -57.2% | ||
| Q2 24 | 0.2% | -83.9% | ||
| Q1 24 | 0.3% | 44.3% |
| Q4 25 | $0.67 | $0.32 | ||
| Q3 25 | $0.30 | $-0.16 | ||
| Q2 25 | $-0.02 | $-0.06 | ||
| Q1 25 | $0.41 | $-0.21 | ||
| Q4 24 | $0.63 | $-0.14 | ||
| Q3 24 | $0.04 | $-0.15 | ||
| Q2 24 | $-0.06 | $-0.33 | ||
| Q1 24 | $-0.06 | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $174.1M | $167.9M |
| Total DebtLower is stronger | $94.7M | — |
| Stockholders' EquityBook value | $294.8M | $-302.0M |
| Total Assets | $521.4M | $465.9M |
| Debt / EquityLower = less leverage | 0.32× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $174.1M | $167.9M | ||
| Q3 25 | $191.3M | $92.4M | ||
| Q2 25 | $174.9M | $86.1M | ||
| Q1 25 | $161.6M | $114.6M | ||
| Q4 24 | $131.9M | $144.8M | ||
| Q3 24 | $135.4M | $144.7M | ||
| Q2 24 | $129.8M | $189.3M | ||
| Q1 24 | $125.3M | $226.6M |
| Q4 25 | $94.7M | — | ||
| Q3 25 | $94.4M | — | ||
| Q2 25 | $94.1M | — | ||
| Q1 25 | $93.7M | — | ||
| Q4 24 | $93.4M | — | ||
| Q3 24 | $93.1M | — | ||
| Q2 24 | $92.8M | — | ||
| Q1 24 | $95.0M | — |
| Q4 25 | $294.8M | $-302.0M | ||
| Q3 25 | $279.3M | $-451.4M | ||
| Q2 25 | $272.2M | $-433.5M | ||
| Q1 25 | $310.0M | $-426.2M | ||
| Q4 24 | $303.9M | $-388.7M | ||
| Q3 24 | $290.4M | $-370.2M | ||
| Q2 24 | $288.7M | $-344.2M | ||
| Q1 24 | $288.5M | $-294.3M |
| Q4 25 | $521.4M | $465.9M | ||
| Q3 25 | $525.3M | $364.0M | ||
| Q2 25 | $537.4M | $347.1M | ||
| Q1 25 | $578.7M | $324.0M | ||
| Q4 24 | $570.1M | $343.8M | ||
| Q3 24 | $569.6M | $314.1M | ||
| Q2 24 | $560.7M | $352.3M | ||
| Q1 24 | $559.0M | $373.1M |
| Q4 25 | 0.32× | — | ||
| Q3 25 | 0.34× | — | ||
| Q2 25 | 0.35× | — | ||
| Q1 25 | 0.30× | — | ||
| Q4 24 | 0.31× | — | ||
| Q3 24 | 0.32× | — | ||
| Q2 24 | 0.32× | — | ||
| Q1 24 | 0.33× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-11.6M | $45.2M |
| Free Cash FlowOCF − Capex | $-15.6M | — |
| FCF MarginFCF / Revenue | -9.9% | — |
| Capex IntensityCapex / Revenue | 2.6% | 0.0% |
| Cash ConversionOCF / Net Profit | -0.92× | — |
| TTM Free Cash FlowTrailing 4 quarters | $46.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-11.6M | $45.2M | ||
| Q3 25 | $21.7M | $-4.3M | ||
| Q2 25 | $14.8M | $-31.4M | ||
| Q1 25 | $37.0M | $-22.6M | ||
| Q4 24 | $1.6M | $-35.0M | ||
| Q3 24 | $14.1M | $-35.3M | ||
| Q2 24 | $12.5M | $-7.2M | ||
| Q1 24 | $20.7M | $53.8M |
| Q4 25 | $-15.6M | — | ||
| Q3 25 | $17.5M | — | ||
| Q2 25 | $11.1M | — | ||
| Q1 25 | $33.1M | — | ||
| Q4 24 | $-1.8M | — | ||
| Q3 24 | $7.8M | $-35.5M | ||
| Q2 24 | $7.3M | $-7.3M | ||
| Q1 24 | $14.5M | $53.8M |
| Q4 25 | -9.9% | — | ||
| Q3 25 | 10.7% | — | ||
| Q2 25 | 6.8% | — | ||
| Q1 25 | 20.1% | — | ||
| Q4 24 | -1.1% | — | ||
| Q3 24 | 5.1% | -68.7% | ||
| Q2 24 | 4.7% | -9.9% | ||
| Q1 24 | 9.4% | 39.0% |
| Q4 25 | 2.6% | 0.0% | ||
| Q3 25 | 2.6% | 0.0% | ||
| Q2 25 | 2.3% | 0.0% | ||
| Q1 25 | 2.4% | 0.0% | ||
| Q4 24 | 2.0% | 0.0% | ||
| Q3 24 | 4.1% | 0.3% | ||
| Q2 24 | 3.4% | 0.1% | ||
| Q1 24 | 4.0% | 0.1% |
| Q4 25 | -0.92× | — | ||
| Q3 25 | 3.90× | — | ||
| Q2 25 | 3.29× | — | ||
| Q1 25 | 4.16× | — | ||
| Q4 24 | 0.12× | — | ||
| Q3 24 | 6.22× | — | ||
| Q2 24 | 33.57× | — | ||
| Q1 24 | 40.20× | 0.88× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
APEI
| American Public Education Inc Segment | $71.0M | 45% |
| Rasmussen University Segment | $66.6M | 42% |
| Hondros College Of Nursing Segment | $20.7M | 13% |
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
